Press Release

06/13/11 Spectrum Pharmaceuticals Inc. Posted on:13 Jun 11 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced the promotion of Steven M. Fruchtman, MD, to the position of Vice President and Chief Medical Officer, and Nozar Azarnia, PhD, to the position of Vice President of ...

+

-

 

Spectrum announces various clinical studies on ZEVALIN at ICML 2011

06/20/11 Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.

+

-

 

Press Release

06/20/11 Spectrum Pharmaceuticals Inc. Posted on:20 Jun 11 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN® (ibritumomab tiuxetan) for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15 ...

+

-